Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cg Oncology Inc (CGON)

Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cg Oncology Inc 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 USA

https://cgoncology.com Employees: 61 P: 949-419-6203

Description:

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,408,735
Enterprise Value, $K 2,400,465
Shares Outstanding, K 67,077
Annual Sales, $ 200 K
Annual Net Income, $ -48,610 K
Last Quarter Sales, $ 110 K
Last Quarter Net Income, $ -18,900 K
EBIT, $ -70,370 K
EBITDA, $ -73,190 K
% of Institutional Shareholders 26.56%
Float, K 67,077
% Float 100.00%
Short Volume Ratio 0.43

Growth:

1-Year Return -1.05%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 08/08/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -0.64
EPS Growth vs. Prev Qtr 22.22%
EPS Growth vs. Prev Year -78.52%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CGON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -24,305.00%
Debt/Equity 0.00
Price/Sales 11,682.58
Price/Cash Flow N/A
Price/Book 4.29
Book Value/Share 8.29
Interest Coverage -3.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar